{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:49:33Z","timestamp":1790272173228,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.yexcr.2021.112785","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T11:06:32Z","timestamp":1629111992000},"page":"112785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells"],"prefix":"10.1016","volume":"407","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-1664","authenticated-orcid":false,"given":"Manju","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1034-0757","authenticated-orcid":false,"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2021.112785_bib1","article-title":"Siffel, epidemiology of Sanfilippo syndrome: results of a systematic literature review","volume":"13","author":"T","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib2","series-title":"The Mucopolysaccharidoses, the Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.yexcr.2021.112785_bib3","article-title":"Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation","volume":"50","author":"T","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexcr.2021.112785_bib4","first-page":"349","article-title":"Tadao, evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by 1 H-magnetic resonance spectroscopy before and after bone marrow transplantation","volume":"49","author":"Orii","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.yexcr.2021.112785_bib5","article-title":"A cure for Sanfilippo syndrome? A summary of current therapeutic approaches and their promise","volume":"8","author":"Iacovino","year":"2020","journal-title":"Med. Res. Arch."},{"key":"10.1016\/j.yexcr.2021.112785_bib6","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.ymgme.2013.12.222","article-title":"Intravenous SBC-103, a recombinant human alpha-N-acetylglucosaminidase reduces CNS heparan sulfate content in a mucopolysaccharidosis type IIIB mouse model","volume":"111","author":"Rutkowski","year":"2014","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.yexcr.2021.112785_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2018.12.003","article-title":"Final results of the phase 1\/2, open-label clinical study of intravenous recombinant human N-acetyl-alpha-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB","volume":"126","author":"Whitley","year":"2019","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.yexcr.2021.112785_bib8","article-title":"Neufeld, mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase","volume":"96","author":"Ef","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2021.112785_bib9","article-title":"Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - a preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism","volume":"174","author":"M","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.yexcr.2021.112785_bib10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drudis.2019.01.007","article-title":"Induced pluripotent stem cells for neural drug discovery","volume":"24","author":"Farkhondeh","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexcr.2021.112785_bib11","article-title":"Chen, passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions","volume":"7","author":"J","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexcr.2021.112785_bib12","article-title":"A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture","volume":"5","author":"J","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2021.112785_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0886-3","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease","volume":"13","author":"Vu","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib14","article-title":"A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells","volume":"8","author":"V","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112785_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2017.1329081","article-title":"Methyl-beta-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK","volume":"13","author":"Dai","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2021.112785_bib16","doi-asserted-by":"crossref","unstructured":"M. Swaroop, R. National Therapeutics for, N.C.f.A.T.S.N.I.o.H.R.M.D.U.S.A. Neglected Diseases, M.J. Brooks, N. Neurobiology, N.E.I.N.I.o.H.B.M.D.U.S.A. Repair Laboratory, L. Gieser, N. Neurobiology, N.E.I.N.I.o.H.B.M.D.U.S.A. Repair Laboratory, A. Swaroop, N. Neurobiology, N.E.I.N.I.o.H.B.M.D.U.S.A. Repair Laboratory, W. Zheng, R. National Therapeutics for, N.C.f.A.T.S.N.I.o.H.R.M.D.U.S.A. Neglected Diseases, Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I, Hum. Mol. Genet. 27 (2020) 3612-3626.","DOI":"10.1093\/hmg\/ddy259"},{"key":"10.1016\/j.yexcr.2021.112785_bib17","article-title":"Fowler, nile red: a selective fluorescent stain for intracellular lipid droplets","volume":"100","author":"Sd","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2021.112785_bib18","doi-asserted-by":"crossref","first-page":"101427","DOI":"10.1016\/j.scr.2019.101427","article-title":"An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene","volume":"37","author":"Huang","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2021.112785_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.5966\/sctm.2013-0080","article-title":"Efficient and rapid derivation of primitive neural stem cells and generation of brain subtype neurons from human pluripotent stem cells","volume":"2","author":"Yan","year":"2013","journal-title":"Stem Cells Trans. Med."},{"key":"10.1016\/j.yexcr.2021.112785_bib20","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/1087057114537378","article-title":"Niemann-pick disease type C: induced pluripotent stem cell-derived neuronal cells for modeling neural disease and evaluating drug efficacy","volume":"19","author":"Yu","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.yexcr.2021.112785_bib21","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.5966\/sctm.2015-0373","article-title":"Induced pluripotent stem cells for disease modeling and evaluation of therapeutics for niemann-pick disease type A","volume":"5","author":"Long","year":"2016","journal-title":"Stem Cells Trans. Med."},{"key":"10.1016\/j.yexcr.2021.112785_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0670-9","article-title":"Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics","volume":"12","author":"Aguisanda","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-018-0798-2","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1\/PPT1) and late infantile (CLN2\/TPP1) neuronal ceroid lipofuscinoses","volume":"13","author":"Sima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112785_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1087057113501197","article-title":"A phenotypic compound screening assay for lysosomal storage diseases","volume":"19","author":"Xu","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.yexcr.2021.112785_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbamcr.2008.11.014","article-title":"Secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Walkley","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.yexcr.2021.112785_bib27","doi-asserted-by":"crossref","first-page":"39349","DOI":"10.1074\/jbc.M112.357707","article-title":"\u03b4-Tocopherol reduces lipid accumulation in niemann-pick type C1 and wolman cholesterol storage disorders*","volume":"287","author":"Xu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2021.112785_bib28","author":"Zheng"},{"key":"10.1016\/j.yexcr.2021.112785_bib29","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1\/PPT1) and late infantile (CLN2\/TPP1) neuronal ceroid lipofuscinoses","volume":"13","author":"N","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib30","article-title":"Zheng, induced pluripotent stem cells for disease modeling and evaluation of therapeutics for niemann-pick disease type A","volume":"5","author":"Y","year":"2016","journal-title":"Stem Cells Trans. Med."},{"key":"10.1016\/j.yexcr.2021.112785_bib31","article-title":"Danos, incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"Heard","year":"2011","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexcr.2021.112785_bib32","article-title":"Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice","volume":"3","author":"Jm","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.yexcr.2021.112785_bib33","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.2353\/ajpath.2010.100447","article-title":"Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB","volume":"177","author":"Vitry","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2021.112785_bib34","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Fa","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.yexcr.2021.112785_bib35","article-title":"Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells","volume":"20","author":"T","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2021.112785_bib36","article-title":"Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans, lipids and lysosomal enzymes in mucopolysaccharidosis type III B (alpha-N-acetylglucosaminidase deficiency)","volume":"31","author":"Ia","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yexcr.2021.112785_bib37","article-title":"Vanier, secondary lipid accumulation in lysosomal disease","volume":"1793","author":"Mt","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2021.112785_bib38","article-title":"Modeling CNS involvement in Pompe disease using neural stem cells generated from patient-derived induced pluripotent stem cells","volume":"10","author":"S","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2021.112785_bib39","article-title":"Ioannou, cyclodextrin induces calcium-dependent lysosomal exocytosis","volume":"5","author":"Ya","year":"2010","journal-title":"PloS One"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482721003384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:38:02Z","timestamp":1757997482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482721003384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0014482721003384"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112785","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2021.112785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112785"}}